Evidence map›Paper›PMID 35223665›Full record

ArticleClinical and experimental vaccine research2022

Protection against virulent

Ayman Al-Mariri, Laila Al-Hallab, Rasha Alabras, Heba Kherbik, Marwa Khawajkiah

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental vaccine research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ayman Al-MaririDepartment of Molecular Biology and Biotechnology, Atomic Energy Commission of Syria, Damascus, Syria.ORCID https://orcid.org/0000-0002-9586-6573
Laila Al-HallabDepartment of Molecular Biology and Biotechnology, Atomic Energy Commission of Syria, Damascus, Syria.ORCID https://orcid.org/0000-0002-4110-9622
Rasha AlabrasDepartment of Molecular Biology and Biotechnology, Atomic Energy Commission of Syria, Damascus, Syria.ORCID https://orcid.org/0000-0002-9832-6820
Heba KherbikDepartment of Molecular Biology and Biotechnology, Atomic Energy Commission of Syria, Damascus, Syria.ORCID https://orcid.org/0000-0003-2488-3357
Marwa KhawajkiahDepartment of Molecular Biology and Biotechnology, Atomic Energy Commission of Syria, Damascus, Syria.ORCID https://orcid.org/0000-0001-7357-3879
Atomic Energy Commission of Syria · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMATERIALS AND

methodsIn this study, we aimed to use the gamma-irradiated

resultsThe humoral immune response in immunized mice with gamma-irradiated

conclusionOur results indicate that the protection of BALB/c mice against

Indexed as

Brucella spp.Cellular and humoral immuneCytokinesGamma raysVaccine

Identifiers

PMID35223665
PMCPMC8844668
OpenAlexW4213021750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.